View Post

FDA approves cancer treatment tested by Penn researchers

In In The News by Barbara Jacoby

By: John Kopp From: Azedra fights rare adrenal gland cancers through radiation Patients with adrenal gland cancers soon will have a new treatment option in their battle against the rare and highly-lethal diseases. The U.S. Food and Drug Administration approved a radiation therapy drug that provides the first non-surgical treatment for the neuroendocrine cancers pheochromocytoma and paraganglioma. The new …